The cellular response elicited by ChAdOx1 nCoV-19 (Astrazeneca) vaccine in a cohort from Rio de Janeiro, Brazil with or without previous SARS-CoV-2 infection

Barros, Tamiris Azamor da Costa; Cunha, Danielle Regina de Almeida de Brito e; Melgaço, Juliana Gil; Tubarão, Luciana Neves; Silva, Jane da; Frederico, Ana Beatriz Teixeira; Setatino, Bruno Pimenta; Horbach, Ingrid Siciliano; Alves, Nathalia dos Santos; Lima, Sheila Maria Barbosa de.
No convencional en Inglés | ARCA | ID: arc-52206

Documentos relacionados

  1. Towards quality improvement of vaccine concept mappings in the OMOP vocabulary with a semi-automated method.
  2. Preventive Pharmacovigilance: timely and precise prevention of adverse events through person-level patient screening and dose-level product surveillance.
  3. Vaccine hesitancy: current and future challenges.
  4. Immune responses to bacterial lung infections and their implications for vaccination.
  5. Self-Assembling Nanoparticles Usher in a New Era of Vaccine Design.
  6. Trained Immunity: Reprogramming Innate Immunity in Health and Disease.
  7. A systematic review of pooled procurement of medicines and vaccines: identifying elements of success.
  8. Modulating Antigen Availability in Lymphoid Organs to Shape the Humoral Immune Response to Vaccines.
  9. [Evaluation of immune persistence of vaccine].
  10. Vaccine development for bacterial pathogens: Advances, challenges and prospects.